Skip to main content

Advertisement

Log in

Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Interleukin-10 (IL-10) is an immunosuppressive cytokine which may facilitate development of cancer by supporting tumor escape from the immune response. A [TCATA] haplotype formed by polymorphisms at positions −3575, −2763, −1082, −819 and −592 in the promoter of the IL-10 gene is a strong determinant for IL-10 expression. The presence of this haplotype can be determined by analysis of the −592C > A polymorphism. Aim of the present study was to analyze the role of the IL-10 [TCATA] haplotype for breast cancer. We performed a case–control study including 500 female patients with histologically confirmed breast cancer and 500 female, age-matched, healthy control subjects from population-based screening studies. The −592C > A polymorphism was determined by a 5′-nuclease assay (TaqMan). Frequency of the homozygous −592 AA genotype, indicating homozygosity for the [TCATA] haplotype, was 4.2% among patients and 7.3% among controls (p=0.038; odds ratio 0.56; 95% confidence interval 0.32–0.97). IL-10 genotypes were not associated with tumor size, histological grading, estrogen or progesterone receptor status and age at diagnosis. Therefore we conclude that the IL-10 −592C > A promoter polymorphism may be associated with a reduced breast cancer risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. S Mocellin F Marincola CR Rossi D Nitti M Lise (2004) ArticleTitleThe multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle Cytokine Growth Factor Rev 15 61–76

    Google Scholar 

  2. MT Lin B Storer PJ Martin LH Tseng T Gooley PJ Chen JA Hansen (2003) ArticleTitleRelation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation N Engl J Med 349 2201–2210

    Google Scholar 

  3. P Krippl U Langsenlehner W Renner B Yazdani-Biuki G Wolf TC Wascher B Paulweber J Haas HA Samonigg (2003) ArticleTitlecommon 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk Int J Cancer 106 468–471

    Google Scholar 

  4. U Langsenlehner P Krippl W Renner B Yazdani-Biuki G Wolf TC Wascher B Paulweber W Weitzer H Samonigg (2003) ArticleTitleThe common 677C > T gene polymorphism of methylenetetrahydrofolate reductase gene is not associated with breast cancer risk Breast Cancer Res Treat 81 169–172

    Google Scholar 

  5. P Krippl U Langsenlehner W Renner B Yazdani-Biuki G Wolf TC Wascher B Paulweber W Weitzer A Leithner H Samonigg (2003) ArticleTitleThe 870G > A polymorphism of the Cyclin D1 gene is not associated with breast cancer Breast Cancer Res Treat 82 165–168

    Google Scholar 

  6. P Krippl U Langsenlehner W Renner B Yazdani-Biuki H Koppel A Leithner TC Wascher B Paulweber H Samonigg (2004) ArticleTitleThe 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer Clin Cancer Res 10 3518–20

    Google Scholar 

  7. RM Scarel-Caminaga PC Trevilatto AP Souza RB Brito LE Camargo SR Line (2004) ArticleTitleInterleukin 10 gene promoter polymorphisms are associated with chronic periodontitis J Clin Periodontol 31 443–448

    Google Scholar 

  8. S George XZ Ruan C Navarrete D Turner M Reynard P Sweny G Hamilton DC Wheeler SH Powis JF Moorhead Z Varghese (2004) ArticleTitleRenovascular disease is associated with low producer genotypes of the anti-inflammatory cytokine interleukin-10 Tissue Antigens 63 470–475

    Google Scholar 

  9. L Giordani P Bruzzi C Lasalandra M Quaranta F Schittulli F Della Ragione A Iolascon (2003) ArticleTitleAssociation of breast cancer and polymorphisms of interleukin-10 and tumor necrosis factor-alpha genes. Clin Chem 49 1664–1667

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Uwe Langsenlehner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Langsenlehner, U., Krippl, P., Renner, W. et al. Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk. Breast Cancer Res Treat 90, 113–115 (2005). https://doi.org/10.1007/s10549-004-3607-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-004-3607-7

Keywords

Navigation